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Preventing Ventilator Associated 
Pneumonia 
Ashley Warner and Becky Dennis 
Cedarville University School of Nursing 
PATIENT CARE ISSUE 
•Most common nosocomial (hospital acquired) infection is VAP 
•Primary concern: Increases morbidity and mortality rates 
•8-28% of critical care patients develop VAP 
•VAP increases length of hospital stay 
•Adds $20,000-40,000 to cost of hospital stay 
•Insurance companies will not cover cost 
 
Question: What is the best method to reduce the occurrence of VAP? 
Purpose: Examine research concerning methods to prevent VAP 
Interventions: VAP/ ventilator bundle 
Compared: Oral care with chlorhexidine, HOB elevation >30⁰, PUD 
prophylaxis, Sedation vacations, subglottic suctioning, silver coated ET 
tubes 
Outcomes: Interventions significantly reduced VAP rates 
 
EVIDENCE-BASED PRACTICE QUESTION 
• Strong relationship between decreased VAP rates and increased 
compliance with VAP bundles 1, 2 
• Combined use of interventions more strongly related to lower VAP rates 
than individual elements alone 3,4 
• Silver-coated endotracheal tubes statistically significant in reducing VAP 
rates 5 
• ISD of secretions statistically significant reduces the incidence of VAP. 6 
• Nearly all interventions effective in reducing VAP, though not in every 
study 
• Oral care with  chlorhexidine and VAP bundles individually most effective 
• Combined interventions considered most effective 
• Studies’ results varied, more testing needed 
 
RESULTS 
SYNTHESIS OF EVIDENCE 
•We searched CINAHL and PubMed 
•Search was limited to the last five years and full text articles 
•PubMed: Search keywords “ventilator associated pneumonia,” 
“prevention of VAP”  
•CINAHL: Search keywords “Prevention of VAP,” “Ventilator Associated 
Pneumonia”, “Research on prevention of ventilator associated 
pneumonia” 
 
METHODS 
• Found 181 articles from CINAHL, 10 relevant (6% relevant) 
• Found 64 articles from PubMed, 4 relevant (6% relevant) 
• After inclusion/exclusion criteria, chose 5 from CINAHL and 4 from 
PubMed 
REGISTERED NURSE INTERVIEW 
•Interviewed a Registered Nurse on the trauma unit at Miami Valley 
Hospital 
•Official policy is vigorous oral care with VAP mouth care kit every 2 hours 
•Brush teeth every 8 hours in addition to VAP mouth care kit 
•Do not use a VAP bundle 
 
• Due to its effectiveness we recommend frequent oral care with 
chlorhexidine 1, 2, 3, 4 
• Further research needs to be conducted due to limited information and 
inconsistencies in VAP bundles  
 
EVIDENCE-BASED PRACTICE RECOMMENDATIONS 
• Not all VAP bundles/protocols are the same, therefore their results are 
not easily compared. 
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